Form 8-K - Current report:
SEC Accession No. 0000200406-24-000031
Filing Date
2024-04-16
Accepted
2024-04-16 07:06:41
Documents
21
Period of Report
2024-04-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jnj-20240416.htm   iXBRL 8-K 37707
2 EX-99.1 a2024q1exhibit991.htm EX-99.1 63915
3 EX-99.2 a2024q1exhibit992.htm EX-99.2 917230
4 EX-99.3 a2024q1exhibit993.htm EX-99.3 5320
9 a1q24overallresultsv2.jpg GRAPHIC 20663
10 a1q24regionalsalesresultsv2.jpg GRAPHIC 10934
11 a1q24segmentsalesperforman.jpg GRAPHIC 11566
12 logo.jpg GRAPHIC 17029
  Complete submission text file 0000200406-24-000031.txt   1339027

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnj-20240416.xsd EX-101.SCH 3333
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnj-20240416_def.xml EX-101.DEF 16713
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnj-20240416_lab.xml EX-101.LAB 30867
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnj-20240416_pre.xml EX-101.PRE 17560
24 EXTRACTED XBRL INSTANCE DOCUMENT jnj-20240416_htm.xml XML 6218
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 24846095
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)